XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS' EQUITY, Restricted Stock and Stock Options (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Plan
$ / shares
shares
Jun. 30, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 16, 2020
shares
Stockholders' Equity Note Details [Abstract]            
Number of stock incentive plans | Plan     3      
Shares [Abstract]            
Outstanding, beginning balance (in shares)     81,000      
Granted (in shares)     0      
Vested (in shares)     0      
Canceled (in shares)     (81,000)      
Outstanding, ending balance (in shares) 0   0   81,000  
Vested (in shares) 0   0      
Exercisable, ending balance (in shares) 0   0      
Weighted Average Exercise Price Per Share [Abstract]            
Outstanding, beginning balance (in dollars per share) | $ / shares     $ 7.79      
Granted (in dollars per share) | $ / shares     0      
Vested (in dollars per share) | $ / shares     0      
Canceled (in dollars per share) | $ / shares     7.79      
Outstanding, ending balance (in dollars per share) | $ / shares $ 0   0   $ 7.79  
Vested or expected to vest (in dollars per share) | $ / shares 0   0      
Exercisable, ending balance (in dollars per share) | $ / shares $ 0   $ 0      
Weighted Average Remaining Contractual Term [Abstract]            
Outstanding         2 months 1 day  
Aggregate Intrinsic Value [Abstract]            
Outstanding, beginning balance | $     $ 0      
Granted | $     0      
Canceled | $     0      
Vested | $     0      
Outstanding, ending balance | $ $ 0   0   $ 0  
Vested or expected to vest | $ 0   0      
Exercisable, ending balance | $ $ 0   $ 0      
Restricted Stock [Member]            
Shares [Abstract]            
Nonvested restricted stock outstanding, beginning balance (in shares)     1,743,846      
Granted (in shares)     606,950      
Canceled (in shares)     0      
Vested (in shares)     (802,530)      
Nonvested restricted stock outstanding, ending balance (in shares) 1,548,266   1,548,266   1,743,846  
Weighted Average Grant Date Fair Value [Abstract]            
Nonvested restricted stock outstanding, beginning balance (in dollars per share) | $ / shares     $ 3.89      
Granted (in dollars per share) | $ / shares     7.21      
Canceled (in dollars per share) | $ / shares     0      
Vested (in dollars per share) | $ / shares     4.18      
Nonvested restricted stock outstanding, ending balance (in dollars per share) | $ / shares $ 5.18   $ 5.18   $ 3.89  
Recognized restricted stock expense | $ $ 500 $ 800 $ 1,700 $ 1,300    
Unrecognized restricted stock expense | $ 7,500   7,500   $ 4,400  
Stock Options [Member]            
Aggregate Intrinsic Value [Abstract]            
Unrecognized pre-tax compensation expense | $ 0   $ 0      
2020 Plan [Member]            
Stockholders' Equity Note Details [Abstract]            
Number of shares available for issuance under incentive plan (in shares)           2,000,000
2020 Plan [Member] | June 16, 2020 [Member]            
Stockholders' Equity Note Details [Abstract]            
Stock option award issuance, plan duration     10 years      
LTIP [Member]            
Stockholders' Equity Note Details [Abstract]            
Number of shares available for issuance under incentive plan (in shares)           2,000,000
LTIP [Member] | Restricted Stock [Member]            
Weighted Average Grant Date Fair Value [Abstract]            
Outstanding restricted shares, intrinsic value | $ 9,800   $ 9,800      
Non Employee Directors Plan [Member]            
Stockholders' Equity Note Details [Abstract]            
Net share settlement for restricted stock (in shares)     268,654 154,973    
Decrease in equity due to payment of tax for employee | $ $ 2,000   $ 2,000 $ 1,000    
Non Employee Directors Plan [Member] | Maximum [Member]            
Stockholders' Equity Note Details [Abstract]            
Decrease in equity due to payment of tax for employee | $   $ 1,000